Home » Newsletters » BioWorld Asia

BioWorld Asia

June 27, 2001

View Archived Issues

Meristem Therapeutics Seeks To Raise US$46M In Paris IPO

Scientists Use Nuclear Transfer To Create Knockout Animal

Bertarelli Says Biotechnology Needs More Support By EU

Changes In Europe, Japan Could Help Alliances With U.S. Firms

Other News To Note

NeuroSearch Raises DKK128.6M For Alzheimers Candidate

European Ministers Give Their Support To Biotechnology

IntegraGen Raises $5.4 Million In Its Initial Funding Round

Cerep Scraps Proposed Offering Because Of Market Conditions

KSB Plans Avicenna Acquisition, Raises #19M Through Placement

Transgene Announces Creation Of Cardiovascular Company

MorphoSys Confirms Filing Of Patent Lawsuit By CAT

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 8, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
Autobahn on the fast track with bipolar thyroid agonist
BioWorld
Achieving high marks in the phase II Amplify-BD trial for bipolar I and II depression, Autobahn Therapeutics Inc.’s elunetirom, a brain-penetrant central nervous...